Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 3
1990 2
1991 1
1992 1
1993 4
1994 4
1997 3
1998 1
1999 4
2001 6
2002 3
2003 4
2004 3
2005 2
2007 1
2008 4
2009 1
2010 2
2011 4
2012 8
2013 2
2014 4
2015 4
2016 2
2017 8
2018 5
2019 4
2020 2
2021 3
2022 7
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

99 results

Results by year

Filters applied: . Clear all
Page 1
Mitochondrial reactive oxygen species trigger metformin-dependent antitumor immunity via activation of Nrf2/mTORC1/p62 axis in tumor-infiltrating CD8T lymphocytes.
Nishida M, Yamashita N, Ogawa T, Koseki K, Warabi E, Ohue T, Komatsu M, Matsushita H, Kakimi K, Kawakami E, Shiroguchi K, Udono H. Nishida M, et al. Among authors: udono h. J Immunother Cancer. 2021 Sep;9(9):e002954. doi: 10.1136/jitc-2021-002954. J Immunother Cancer. 2021. PMID: 34531248 Free PMC article.
DNA Droplets: Intelligent, Dynamic Fluid.
Udono H, Gong J, Sato Y, Takinoue M. Udono H, et al. Adv Biol (Weinh). 2023 Mar;7(3):e2200180. doi: 10.1002/adbi.202200180. Epub 2022 Dec 5. Adv Biol (Weinh). 2023. PMID: 36470673 Review.
Immunotherapy for Bone and Soft Tissue Sarcomas.
Uehara T, Fujiwara T, Takeda K, Kunisada T, Ozaki T, Udono H. Uehara T, et al. Among authors: udono h. Biomed Res Int. 2015;2015:820813. doi: 10.1155/2015/820813. Epub 2015 Jun 17. Biomed Res Int. 2015. PMID: 26167500 Free PMC article. Review.
CD8+ T-cell Responses Are Boosted by Dual PD-1/VEGFR2 Blockade after EGFR Inhibition in Egfr-Mutant Lung Cancer.
Nishii K, Ohashi K, Tomida S, Nakasuka T, Hirabae A, Okawa S, Nishimura J, Higo H, Watanabe H, Kano H, Ando C, Makimoto G, Ninomiya K, Kato Y, Kubo T, Ichihara E, Hotta K, Tabata M, Toyooka S, Udono H, Maeda Y, Kiura K. Nishii K, et al. Among authors: udono h. Cancer Immunol Res. 2022 Sep 1;10(9):1111-1126. doi: 10.1158/2326-6066.CIR-21-0751. Cancer Immunol Res. 2022. PMID: 35802887 Free article.
99 results